Home/Filings/4/0001209191-18-033927
4//SEC Filing

Presnell Sharon Collins 4

Accession 0001209191-18-033927

CIK 0001497253other

Filed

May 28, 8:00 PM ET

Accepted

May 29, 5:44 PM ET

Size

7.9 KB

Accession

0001209191-18-033927

Insider Transaction Report

Form 4
Period: 2018-05-24
Presnell Sharon Collins
EVP, Research & Development
Transactions
  • Award

    Common Stock

    2018-05-24+74,380343,848 total
  • Award

    Stock Option (Right to Buy)

    2018-05-24+300,000300,000 total
    Exercise: $1.84Exp: 2028-05-24Common Stock (300,000 underlying)
Footnotes (4)
  • [F1]Annual long-term equity award approved by the Compensation Committee of the Issuer's Board of Directors.
  • [F2]The shares represent a grant of Restricted Stock Units ("RSUs"). The RSUs represent a right to receive shares of the Issuer's common stock, at no additional conversion or exercise price. The RSUs vest and settle over 16 equal quarterly installments measured from May 15, 2018.
  • [F3]This number does not include 1,582,192 shares of common stock underlying outstanding options held by Dr. Presnell; post-transaction Dr. Presnell beneficially owns or has a right to acquire 1,926,040 shares of common stock.
  • [F4]The option shares vest and become exercisable over 16 equal quarterly installments measured from May 15, 2018.

Issuer

ORGANOVO HOLDINGS, INC.

CIK 0001497253

Entity typeother

Related Parties

1
  • filerCIK 0001536585

Filing Metadata

Form type
4
Filed
May 28, 8:00 PM ET
Accepted
May 29, 5:44 PM ET
Size
7.9 KB